Skip to main content
About the Institute
  • English
  • Français
  • Español
  • Russian
  • Portuguese
  • Polish

Breadcrumb

  1. Home
  2. Gastroenterology
  3. Dengue and Zika: protecting mosquitoes to protect humans
  • Our publications
    • News
    • Microbiota Mag
    • Thematic pages
    • Experts' point of view
    • Thematic folders
    • Overviews - Microbiota Magazine
  • About the Institute
    • About us
    • International Microbiota Observatory
    • Press room
    • Partnerships
  • Congresses
    • Congress calendar
    • Congress reviews
  • Continuing Medical Education
    • Accrediting courses
  • Useful documents
    • How to talk about
    • Infographics
    • IBS Diagnosis Check List
    • Patients Stories

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube
    • Instagram
    • Bluesky

Lay public section

Find here your dedicated section
Gastroenterology
Gynecology
Pediatrics
General Medicine

Breadcrumb

  1. Home
  2. Gastroenterology
  3. Dengue and Zika: protecting mosquitoes to protect humans
Gastroenterology

Dengue and Zika: protecting mosquitoes to protect humans

Exposome
Gastroenterology General Medicine Dermatology

Inoculating mosquitoes by introducing the Rosenbergiella_YN46 bacterium into their digestive system: a realistic and sustainable biological control strategy for reducing the transmission and prevalence of flaviviruses in the wild?

Gastroenterology
Gynecology
Pediatrics
General Medicine
  • Our publications
    • News
    • Microbiota Mag
    • Thematic pages
    • Experts' point of view
    • Thematic folders
    • Overviews - Microbiota Magazine
  • About the Institute
    • About us
    • International Microbiota Observatory
    • Press room
    • Partnerships
  • Congresses
    • Congress calendar
    • Congress reviews
  • Continuing Medical Education
    • Accrediting courses
  • Useful documents
    • How to talk about
    • Infographics
    • IBS Diagnosis Check List
    • Patients Stories

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube
    • Instagram
    • Bluesky

Lay public section

Find here your dedicated section

Sources

This article is based on scientific information

Sharing is caring

Your colleagues might be interested in this topic. Why not share it?

  • Facebook
  • Twitter
  • LinkedIn
  • Mail

About this article

Created 04 October 2024
Updated 10 February 2025

Mosquito-borne flaviviruses such as Zika, Dengue, West Nile virus, and yellow fever are potentially fatal to humans. The cause for concern is greater still given that climate change and phenomena such as El Niño favor such (sidenote: Vector-borne disease A disease where a pathogen is transmitted to a host (human or animal) by the bite of a vector, such as mosquitoes, flies, ticks, or fleas. 
Vector-borne diseases account for around 17% of all infectious diseases worldwide, with the WHO estimating that 80% of the world’s population lives at risk from at least one vector-borne disease.
 
Explore https://www.pasteur.fr/fr/innovation/toute-actualite/actualites-innovation/comb… )
, while mosquito control and population biological control campaigns have had limited impact to date.

What about adopting an entirely different strategy? Modifying the mosquito’s gut microbiota may protect it from infection and hence prevent it from transmitting the virus to mammals, including humans.

A tenfold increase in cases worldwide

Between 2000 and 2019, the World Health Organization (WHO) 1 reported a tenfold increase in the number of dengue fever cases worldwide, from 500,000 to 5.2 million.

After a slight decline during the COVID-19 pandemic, an upsurge in dengue fever cases was observed worldwide in 2023.

Bacterium that protects both mosquito and human

In this study, Chinese researchers 2 isolated 55 bacteria living in the digestive system of female Aedes albopictus mosquitoes, the main vector of Dengue fever, from insects captured in southern Yunnan. These bacteria included Rosenbergiella_YN46 (so named because it was identified in Yunnan), which, inoculated at a dose of 1.6 × 103 CFU (colony forming units), provided A. albopictus with persistent protection against (sidenote: Flavivirus is a genus of viruses which consists of >70 members including several that are considered significant human pathogens. Transmitted to humans through the bite of infected mosquitoes, Flaviviruses display a broad spectrum of diseases that can be roughly categorised into two phenotypes:
- systemic disease involving haemorrhage (Dengue and yellow Fever virus)
- and neurological complications (West Nile and Zika viruses)
Explore https://pubmed.ncbi.nlm.nih.gov/34696709/ )
.

How does this gut bacterium found in flower nectar enable A. albopictus and Aedes aegypti mosquitoes to resist infection by Dengue and Zika? By secreting a glucose dehydrogenase that converts glucose into gluconic acid, rapidly acidifying the mosquito’s intestinal lumen (pH < 6.5 after a blood meal). This acidic environment irreversibly modifies the protein envelope of flavivirus virions, preventing them from entering the mosquito’s gut epithelial cells.

390 million With up to 390 million people infected each year, dengue fever is the most common mosquito-borne flavivirus worldwide. ²

223,000 There were 223,000 confirmed cases of Zika infection in the Pacific Islands and the Americas between 2015 and 2017. ²

Effective strategy on a large scale?

But the researchers’ work did not stop there. Noting that Dengue prevalence varied between prefectures of Yunnan province, they wanted to see whether this phenomenon went hand in hand with an uneven presence of the bacterium. Indeed it did. Rosenbergiella_YN46 was more prevalent in the digestive system of mosquitoes from Wenshan (91.7%) and Pu’er (52.9%) prefectures, where only a few isolated cases of Dengue have been reported, while the bacterium was rare in mosquitoes from Xishuangbanna (6.7%) and Lincang (0%) prefectures, where Dengue is endemic. 

Complementary experiments under semi-field conditions provide hope of a possible (sidenote: biological control Biological control is an environmentally sound and effective means of reducing or mitigating pests and pest effects through the use of natural enemies.  Explore https://www.sciencedirect.com/journal/biological-control ) : sugar water laced with Rosenbergiella_YN46 suffices to contaminate the mosquito, with the bacterium then efficiently transmitted (sidenote: Transstadial transmission The vector (here, the mosquito) retains an agent (in this case, the flavivirus) in its body as it passes from one stage of development to another (here, from aquatic larva to winged adult). Explore Źródło ) , and from generation to generation (in mosquitoes, the gut microbiota is transmitted by the female mosquito to its offspring through larval and adult feeding).

Furthermore, introducing Rosenbergiella_YN46 into the aquatic habitat of larvae, or importing adults already carrying the bacterium, may reduce Dengue transmission in areas where the disease is endemic.

Sources

1. https://www.who.int/en/emergencies/disease-outbreak-news/item/2023-DON498

2. Zhang L, Wang D, Shi P et al. A naturally isolated symbiotic bacterium suppresses flavivirus transmission by Aedes mosquitoes. Science. 2024 Apr 19;384(6693):eadn9524.

Tags
Mosquito Exposome Viral Microbiome Flora

    See also

    Actu PRO : Le microbiote, rempart contre le rotavirus The microbiota as a barrier against rotavirus
    Skin diseases associated with a dysbiosis
    Created 04 October 2024
    Updated 10 February 2025

    About this article

    To know more about this topic.

    Main topic

    Exposome

    Medical practice

    Gastroenterology General Medicine Dermatology

    Content type

    News
    • Our publications
      • News
      • Microbiota Mag
      • Thematic pages
      • Experts' point of view
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • About us
      • International Microbiota Observatory
      • Press room
      • Partnerships
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
    • Useful documents
      • How to talk about
      • Infographics
      • IBS Diagnosis Check List
      • Patients Stories

      Join the microbiota community

      • Facebook
      • Twitter
      • LinkedIn
      • YouTube
      • Instagram
      • Bluesky

    Lay public section

    Find here your dedicated section
    Gastroenterology
    Gynecology
    Pediatrics
    General Medicine
    • English
    • Français
    • Español
    • Russian
    • Portuguese
    • Polish

    Browse the site

    • Our publications
      • News
      • Microbiota Mag
      • Thematic pages
      • Experts' point of view
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • About us
      • International Microbiota Observatory
      • Press room
      • Partnerships
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
    • Useful documents
      • How to talk about
      • Infographics
      • IBS Diagnosis Check List
      • Patients Stories

      Join the microbiota community

      • Facebook
      • Twitter
      • LinkedIn
      • YouTube
      • Instagram
      • Bluesky

    Lay public section

    Find here your dedicated section

    Discover

    Gastroenterology
    Gynecology
    Pediatrics
    General Medicine

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube
    • Instagram
    • Bluesky

    Lay public section

    Find here your dedicated section

    Redirection

    You are about to be redirected and leave our website

    • Be redirected
    • Stay on the Biocodex Microbiota Institute's website

    Stay with us !

    Join the Microbiota Community of HCPs and researchers and receive “Microbiota Digest” and "Microbiota Mag" to stay up to date on the latest news about microbiota.

    * Mandatory Fields

    BMI 20-35

    Explore

    14.05.2025

    Towards worldwide redefinition of healthy vaginal microbiota

    Read the article
    07.05.2025

    The microbial-metabolic nexus in colon cancer

    Read the article
    02.05.2025

    A new lens on chlamydia: beyond behavior, into the microbiome

    Read the article

    Stay updated

    Join the Microbiota Community of HCPs and researchers and receive “Microbiota Digest” and "Microbiota Mag" to stay up to date on the latest news about microbiota.

    * Mandatory Fields

    BMI 20-35

    • Our publications
      • News
      • Microbiota Mag
      • Thematic pages
      • Experts' point of view
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • About us
      • International Microbiota Observatory
      • Press room
      • Partnerships
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
    • Useful documents
      • How to talk about
      • Infographics
      • IBS Diagnosis Check List
      • Patients Stories

      Join the microbiota community

      • Facebook
      • Twitter
      • LinkedIn
      • YouTube
      • Instagram
      • Bluesky

    Lay public section

    Find here your dedicated section

    Discover

    Gastroenterology
    Gynecology
    Pediatrics
    General Medicine

    Lay public section

    Find here your dedicated section

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube
    • Instagram
    • Bluesky

    © 2025 Biocodex. All rights reserved.

    • Legal notice
    • GTU
    • Data protection policy
    • Sitemap
    • Cookies settings
    • Digital accessibility : partially compliant
    Biocodex logo